Compliance with antihypertensive treatment

Clinical and Experimental Hypertension

Volumn 18, Issue 3-4, 1996, Pages 463-472

  Costa, Francesco Vittorio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; ELASTICITY; HUMAN; HYPERTENSION;

EID: 0029871303     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609088977     Document Type: Conference Paper

References (20)

1. Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DL ,eds. Compliance in health care, baltimore: Johns Hopkins University Press, 1979; 1-7.
2. Saunders CE. patient compliance in filling prescriptions after discharge from the mergency department. Am J Emerg Med 1987;5:283-286.
3. Brand FN, Smith RT, Brand PA. Effect of economic barriers to medical care on patient's noncompliance. Public Health Rep 1977; 92: 72-78.
4. Nelson EC, Stason WB, Neutra RR, Solomon HS: Identification of the noncompliant hypertensive patient. Prev Med 1980; 9:504-517.
5. Haynes RB, Sackett DL, taylor DW, Roberts RS, Johnson AL. Manipulation of the therapeutic regimen to imrove compliance : conceptions and misconceptions. Clin Pharmacol Ther 1977;22:125-130.
6. Hilka BS. patient-clinician interactions and compliance. In : Haines RB, taylor DW, Sackett DL eds. compliance in health care, baltimore; Johns Hopkins University Press, 1967;63-77.
7. Kubacka RT, Juhl RP. Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. Am J Hosp Pharm 1985;42:2499-2501.
8. Taggart AJ, Johnston GD, Mcdevitt DG. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1981;1:31-34.
9. Ley P . Understanding , memory, satisfaction and compliance . Br J Clin Psychol 1982;21:241-254.
10. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
11. Williams GH. Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents. Am J Kidney Dis 1987 ;10 (Suppl 1): 61-65.
12. Ley P. Doctor- patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypoertens 1985 ;3 (Suppl 1) :51-55.
13. Mollica JA. Monitoring compliance through analysis of drug and metabolite levels. Contrib Clin Trials 1984;5:505-514.
14. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting: comparison of three methods in patients prescribed digoxin. Arch Intern Med 1979; 139:635-638.
15. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care 1987; 2:23-35.
16. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D Improved compliance measures: applications in ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990; 48:676-685.
17. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associted with recently stopping the use of beta blockers. JAMA 1990;263:1653-1657.
18. Glanz K, Kirscht JP, Rosenstock IM. Linking research and practice in patient education for hypertension , patient responses to four educational interventions Med Care 1981;19:141-152.
19. Mullen PD, Green LW, Persinger GS: Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. Prev Med 1985; 14:753-781.
20. Edmonds D, Foerster E, Groth H, Greminger P, Siegenthaler W, Vetter W. Does self measurement of blood pressure improve patient compliance in hypertension? J Hypertens 1985 ;3 (suppl 1):31-34.